Correlation Between Zura Bio and Altamira Therapeutics
Can any of the company-specific risk be diversified away by investing in both Zura Bio and Altamira Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zura Bio and Altamira Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zura Bio Limited and Altamira Therapeutics, you can compare the effects of market volatilities on Zura Bio and Altamira Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zura Bio with a short position of Altamira Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zura Bio and Altamira Therapeutics.
Diversification Opportunities for Zura Bio and Altamira Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Zura and Altamira is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Zura Bio Limited and Altamira Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Altamira Therapeutics and Zura Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zura Bio Limited are associated (or correlated) with Altamira Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Altamira Therapeutics has no effect on the direction of Zura Bio i.e., Zura Bio and Altamira Therapeutics go up and down completely randomly.
Pair Corralation between Zura Bio and Altamira Therapeutics
If you would invest (100.00) in Altamira Therapeutics on December 29, 2024 and sell it today you would earn a total of 100.00 from holding Altamira Therapeutics or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Zura Bio Limited vs. Altamira Therapeutics
Performance |
Timeline |
Zura Bio Limited |
Altamira Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Zura Bio and Altamira Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Zura Bio and Altamira Therapeutics
The main advantage of trading using opposite Zura Bio and Altamira Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zura Bio position performs unexpectedly, Altamira Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altamira Therapeutics will offset losses from the drop in Altamira Therapeutics' long position.Zura Bio vs. Lipocine | Zura Bio vs. Asure Software | Zura Bio vs. Clearmind Medicine Common | Zura Bio vs. FARO Technologies |
Altamira Therapeutics vs. Pyxis Oncology | Altamira Therapeutics vs. Zura Bio Limited | Altamira Therapeutics vs. Elevation Oncology | Altamira Therapeutics vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |